Science & Research
Psychology of First Impressions Offers Critical Business Strategy Insights
Recent psychological research reveals how first impressions shape business credibility, environmental influence on decision-making, and the disproportionate weight of small details in professional interactions.
Clene's CNM-Au8 Shows Promising Brain Energy Improvements in Multiple Sclerosis Patients
Clene Inc. presented positive trial results demonstrating that its investigational therapy CNM-Au8 significantly improved brain energy metabolism in multiple sclerosis patients, potentially offering a new approach to slowing disease progression by addressing underlying bioenergetic failure.
Study Reveals Common Nutrient May Enhance Cancer-Fighting Immune Cells
University of Chicago research indicates zeaxanthin, a nutrient found in common vegetables, could boost immune system effectiveness against cancer while complementary therapies like oncolytic viruses advance.
Cognitive Alignment Emerges as New Productivity Paradigm Beyond Traditional Discipline
The article explores how Cognitive Alignment and State-to-Task Matching represent a fundamental shift in productivity approaches by focusing on matching mental states with task demands rather than relying solely on discipline and time management.
Undergraduate Research at Massachusetts Maritime Academy Contributes to Polar Ecosystem Understanding
A Massachusetts Maritime Academy student's co-authorship of a peer-reviewed study on polar marine microbiomes demonstrates the significant impact undergraduate research can have on advancing scientific understanding of climate-critical ecosystems.
Soligenix Advances HyBryte Treatment for Cutaneous T-Cell Lymphoma with FLASH Trial Results
Soligenix is strengthening its position in CTCL treatment through promising results from its HyBryte FLASH studies, representing significant progress toward establishing a new standard of care in an underserved therapeutic area.
Cybin Advances Neuropsychiatry Pipeline with Key Clinical Milestones and Extended IP Protection
Cybin Inc. is progressing multiple late-stage clinical programs for mental health treatments, with upcoming data readouts and regulatory advancements that could significantly impact the neuropsychiatry treatment landscape.
Oncotelic's Joint Venture Sapu Nano Receives Approval for Phase 1 Trial of Injectable Everolimus for Breast Cancer
Sapu Nano's approval to begin Phase 1 clinical trials for an injectable version of Everolimus represents a potential breakthrough in breast cancer treatment by enabling full drug absorption compared to the oral version's limited 10% bioavailability.
Rehabilitated Loggerhead Sea Turtle 'Pegasus' Set for Release with Satellite Tracking
The New York Marine Rescue Center's release of a rehabilitated loggerhead sea turtle equipped with a satellite tag provides crucial data for marine conservation and demonstrates successful cross-institutional collaboration in wildlife rehabilitation.
UK Startup Achieves Quantum Computing Breakthrough Using Standard Silicon Chips
A UK startup has developed the first quantum computer using standard silicon chips, potentially democratizing quantum technology by reducing costs and eliminating the need for specialized components.
GeoVax Expands Gedeptin Cancer Therapy Development to Additional Solid Tumor Types
GeoVax Labs is expanding its Gedeptin cancer therapy development to include triple negative breast cancer and cutaneous malignancies, building on checkpoint inhibitor momentum and KEYNOTE-689 results to potentially improve outcomes for broader solid tumor patients.
Stanford's Fatima Rodriguez Receives Prestigious 2025 Joseph A. Vita Award for Cardiovascular Research
Dr. Fatima Rodriguez's recognition with the Joseph A. Vita Award highlights significant advancements in personalized cardiovascular risk prediction and prevention strategies that address health disparities across diverse populations.
Quantumzyme Corp. Secures Patent for Sustainable Ibuprofen Manufacturing Process
Quantumzyme Corp. has achieved a significant milestone with the USPTO publication of its patent for an enzymatic ibuprofen synthesis method, representing a major advancement in sustainable pharmaceutical manufacturing.
Creative Biolabs Launches Advanced Antibody Tools for Neuroscience Research
Creative Biolabs has developed specialized antibody products targeting key neurological proteins that could accelerate research into neurodegenerative diseases, movement disorders, and synaptic function.
New Research Reveals Listening Skills as Critical Factor in Relationship Success
Oliver Drakeford Therapy's study demonstrates that strong listening skills can increase the likelihood of thriving relationships by 43 times, highlighting the transformative power of effective communication in couples therapy.
LabConnect and The Bracken Group Forge Strategic Partnership to Enhance Radiopharmaceutical Trial Support
LabConnect's collaboration with The Bracken Group addresses the growing demand for specialized radiopharmaceutical expertise in clinical trials, positioning the partnership to better serve biotech and pharmaceutical companies developing targeted treatments and diagnostics.
Leading Mental Health Expert to Address Youth Crisis at Biofeedback Conference
Dr. Roseann Capanna-Hodge will present brain-based strategies for addressing the youth mental health crisis at the NRBS 2025 conference, offering practical solutions for clinicians, educators, and parents dealing with rising rates of anxiety and depression.
New York Architect Meshal Alradadi Gains International Recognition for Data-Driven Design Approach
Meshal Alradadi's innovative work merging architecture with information systems represents a significant shift toward data-driven design processes that could transform how buildings are conceptualized and constructed.
Researchers Challenge Biochar's Role in Boosting Biogas Production, Calling for More Rigorous Evidence
Scientists question whether conductive additives like biochar truly enhance biogas production through direct electron transfer, highlighting the need for standardized research to validate claims that could revolutionize renewable energy from organic waste.
Circular DNA Fragments Identified as Key Factor in Glioblastoma Lethality
International researchers have discovered that rogue circular DNA fragments operating independently from chromosomes may explain why glioblastoma remains so deadly despite medical advances, potentially opening new treatment pathways.
A. Aubrey Bodine Archive Offers Glimpse Into Mid-Century Maryland Through 6,000 Photographs
The extensive photographic archive of A. Aubrey Bodine, featuring over 6,000 images documenting mid-20th century Maryland life, provides valuable historical insight and artistic legacy through his pioneering pictorialist approach.
MUSC Professor Daniel Lackland to Receive 2025 Population Research Prize for Hypertension Research
Dr. Daniel Lackland's recognition by the American Heart Association highlights the critical importance of population-level research in addressing cardiovascular health disparities and improving hypertension treatment strategies globally.
GeoVax Reaffirms Commitment to Vaccine Safety Amid Development of GEO-CM04S1 for Immunocompromised Patients
GeoVax Labs emphasizes its evidence-based approach to vaccine safety and the advancement of GEO-CM04S1, a COVID-19 vaccine designed for vulnerable populations with weakened immune systems who respond poorly to current options.
Psychological Distress After Heart Attack Linked to Increased Risk of Future Cardiac Events
New research reveals that psychological distress affects up to 50% of heart attack survivors and increases the risk of future cardiac events by 1.3 to 2 times, highlighting the critical need for integrated mental health care in cardiac recovery.
Alicia Kali Establishes World's First Neuroscience and BioQuantum Engineering Institute to Advance Human Health and AI Performance
Alicia Kali has launched the world's first nonprofit institute dedicated to neuroscience and bioquantum engineering, aiming to unify biological intelligence, regenerative health, and artificial cognition through groundbreaking research.
Soligenix Advances Oral Mucositis Treatment SGX942 with Combined Clinical Data Analysis
Soligenix is leveraging positive phase 2 and 3 clinical data to design a second pivotal trial for SGX942, addressing the critical unmet medical need for oral mucositis treatment in cancer patients.
LaFleur Minerals Reports Promising Sulphide-Rich Mineralized Zone in Swanson Gold Project Drilling
LaFleur Minerals has identified a significant sulphide-rich mineralized zone at least 17.9 meters wide during its Swanson Gold Project drilling program in Quebec's Abitibi Greenstone Belt, indicating potential for substantial gold discovery.
Lantern Pharma Completes Japan Enrollment in Phase 2 Trial for Never-Smoker Lung Cancer Treatment
Lantern Pharma has achieved targeted patient enrollment in Japan for its Phase 2 HARMONIC trial evaluating LP-300 in never-smoker non-small cell lung cancer patients, marking significant progress in addressing an underserved population with high unmet medical need.
UCLA Researchers Awarded $2M Grant for MRI-Guided Cancer Radiation Therapy Study
UCLA Health receives a $2 million grant from ViewRay Systems to advance research on MRI-guided radiation therapy for targeted cancer treatment, highlighting growing investment in precision oncology technologies.
Lexaria's DehydraTECH Shows Enhanced Brain Delivery of Semaglutide in Preclinical Study
Lexaria Bioscience's drug delivery technology demonstrated improved brain distribution of GLP-1 drug semaglutide in rodents, potentially leading to better safety and efficacy for weight loss treatments.